News
- Author:
- Kate Johnson
Publish date: October 1, 2024
“Pregnant women with higher amygdala activity were less able to regulate their emotions successfully compared to those with less amygdala activity....
News
- Author:
- Kate Johnson
Publish date: September 30, 2024
Rapid diagnosis and treatment of NMO “means potentially preventing future devastating neurologic inju...
News
- Author:
- Kate Johnson
Publish date: September 30, 2024
“Sex hormones may modulate treatment response, potentially supporting sex-specific pharmacological intervention.”
News
- Author:
- Kate Johnson
Publish date: September 26, 2024
Current research investigating GLP-1s in psychiatry and neurology is increasingly focused on neuroinflammation.
News
- Author:
- Kate Johnson
Publish date: September 24, 2024
“The study suggests that psilocybin therapy might be a more holistic treatment option for depression.”
News
- Author:
- Kate Johnson
Publish date: August 26, 2024
Real-world meta-analysis finds benefit of later-line liposomal irinotecan is not attenuated by prior conventional irinotecan.
News
- Author:
- Kate Johnson
Publish date: August 12, 2024
The results “underscore the importance of judicious prescribing, with preferential use of antibiotics associated with a lower risk when clinically ...
News
- Author:
- Kate Johnson
Publish date: July 30, 2024
A large Italian study found real-world differences in short-term outcomes among first line CDK4/6 inhibitors palbociclib, ribociclib and abemacicli...
News
- Author:
- Kate Johnson
Publish date: July 26, 2024
Retrospective analysis finds no clinical trial enrollment, reduced use of targeted treatment, and shortened survival.
News
- Author:
- Kate Johnson
Publish date: July 17, 2024
Authors investigate cognitive functioning in the same cohort used in the SONIA trial and a matched control group of individuals that did not have c...
News
- Author:
- Kate Johnson
Publish date: July 10, 2024
Patients with HER2-positive, locally advanced or metastatic breast cancer who cannot tolerate the standard taxane-based regimen have a new option f...
News
- Author:
- Kate Johnson
Publish date: July 10, 2024
Palbociclib plus endocrine therapy or chemotherapy: Which is best in HR+/HER2- metastatic breast cancer?
News
- Author:
- Kate Johnson
Publish date: July 8, 2024
Researchers conduct first randomized phase 3 trial of patients with TNBC treated with adjuvant avelumab.
News
- Author:
- Kate Johnson
Publish date: June 26, 2024
“Nfl after a single cycle could detect axonal degeneration,” says the lead author of new research.
News
- Author:
- Kate Johnson
Publish date: June 19, 2024
An expanded analysis of the INAVO120 trial looks at time from randomization to end of next-line treatment, time to first chemotherapy, and patient-...
